TOP TIERMARKET NEWSWIRE
News & sentiment

ARMATA PHARMACEUTICA (ARMP) — News & AI sentiment

ARMATA PHARMACEUTICA (ARMP) news roundup. 4 stories in the past week, 4 over 30 days. Average 30-day sentiment is 57.8/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 57.8/100
30d stories
4
avg sentiment 57.8/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ARMP news in the last 24 hours, 7 days, 30 days and 90 days

How much ARMP coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowARMP storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days457.8/100ARMP headlines →
Last 30 days457.8/100ARMP headlines →
Last 90 days2361.7/100ARMP headlines →

Latest stories on ARMP

1d ago
1d ago
1d ago
1d ago
Oct 7
Oct 7
Sep 23
Sep 23
Sep 23
Sep 23
Sep 22
Sep 21
Roundhill ARM WeeklyPay ETF declares $0.6674 dividend
Business Insider50 · neutralgeneral
Sep 21
Sep 14
Sep 14
Armata Pharmaceuticals stock rises on FDA breakthrough designation
Investing.com Markets67 · bullishproduct/pr
Sep 14
Sep 14
Sep 14
Sep 14
Sep 14
Sep 10
Sep 3
Sep 3
Aug 12
Aug 12
Open ARMP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →